Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-25-063849
Filing Date
2025-06-30
Accepted
2025-06-30 08:29:31
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM S-1/A tm2516057d4_s1a.htm S-1/A 696457
2 EXHIBIT 4.2 tm2516057d4_ex4-2.htm EX-4.2 107303
3 EXHIBIT 4.3 tm2516057d4_ex4-3.htm EX-4.3 105715
4 EXHIBIT 4.4 tm2516057d4_ex4-4.htm EX-4.4 103634
5 EXHIBIT 5.1 tm2516057d4_ex5-1.htm EX-5.1 20577
6 EXHIBIT 23.2 tm2516057d4_ex23-2.htm EX-23.2 3251
7 GRAPHIC tm2516057d3_s1img001.jpg GRAPHIC 37271
8 GRAPHIC tm2516057d4_ex5-1img001.jpg GRAPHIC 2604
  Complete submission text file 0001104659-25-063849.txt   1093368
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

EIN.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-288333 | Film No.: 251088834
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)